Fig. 12From: The new world of RNA diagnostics and therapeuticsc-Myc-dependent transcription activation of a signature of mRNAs allows the acquisition of resistance to the alpelisib treatment, in patient-derived xenografts of head and neck squamous cell carcinomaBack to article page